India’s digital healthcare market has witnessed exponential growth over the last six years, driven by increased internet penetration, mobile-first consumers, and rising demand for affordable medicines. Online pharmacy platforms such as PharmEasy, 1mg, and Netmeds collectively list more than one million medicine SKUs daily, covering branded drugs, generics, OTC products, wellness items, and prescription-based therapies. Tracking Medicine Prices - PharmEasy, 1mg & Netmeds has become a critical requirement for pharmaceutical companies, healthcare aggregators, insurers, and analytics firms seeking transparency in pricing behavior and discount strategies.
Medicine prices across platforms fluctuate frequently due to dynamic discounting, subscription offers, flash sales, regional supply variations, and regulatory changes. Between 2020 and 2026, these fluctuations intensified, making manual price tracking inaccurate and unsustainable. Web scraping enables structured, automated, and scalable extraction of medicine pricing data across platforms, allowing businesses to analyze historical trends, identify pricing gaps, and respond to real-time market changes. With accurate datasets, stakeholders gain visibility into affordability, competition, and long-term pricing sustainability in India’s evolving online pharma ecosystem.
Understanding pricing behavior on PharmEasy requires granular visibility across therapy types, pack sizes, and discount models. Through Medicine price scraping From PharmEasy, businesses can analyze how platform-driven pricing strategies have evolved from 2020 onward. PharmEasy’s aggressive discounting during the pandemic years significantly reshaped consumer expectations, especially for chronic medicines.
From 2020 to 2022, average discounts increased sharply as PharmEasy expanded its user base. Subscription-led pricing models further stabilized demand while compressing margins. By 2024, pricing became more balanced, with discounts strategically applied to high-volume SKUs rather than across-the-board reductions. Forecasts through 2026 indicate moderate discount growth, emphasizing retention rather than acquisition.
| Year | Avg. Discount % | Chronic Drug Price Variance | OTC Price Variance |
|---|---|---|---|
| 2020 | 12% | 3% | 10% |
| 2021 | 18% | 3.5% | 12% |
| 2022 | 22% | 4% | 14% |
| 2023 | 24% | 4% | 14% |
| 2024 | 25% | 4% | 15% |
| 2026 (Proj.) | 28% | 4% | 16% |
These insights help pharmaceutical suppliers understand pricing stability, promotional intensity, and long-term profitability on PharmEasy.
Price competition on 1mg is largely driven by brand-versus-generic substitution. Using 1mg Medicine price monitoring, analysts can track how consumers increasingly shift toward lower-priced generics without sacrificing perceived quality. From 2020 to 2026, the share of generic medicines increased steadily, driven by affordability and growing trust in alternative formulations.
Generic medicines on 1mg are consistently priced 35–60% lower than branded equivalents, while maintaining average ratings above 4.5. This shift has forced branded drug manufacturers to re-evaluate pricing, packaging, and discount strategies to remain competitive.
| Category | Avg. Price Drop | Avg. Rating | Market Share Growth |
|---|---|---|---|
| Generic Medicines | 42% | 4.5 | +28% |
| Branded Medicines | 18% | 4.6 | –12% |
| Supplements | 22% | 4.4 | +15% |
These trends offer actionable insights for pricing optimization, portfolio restructuring, and demand forecasting.
Netmeds positions itself as a price-competitive alternative with a strong focus on chronic therapies and repeat purchases. Through Netmeds Medicine price comparison, businesses can identify category-level pricing advantages and premium segments.
Historical data shows that Netmeds consistently undercuts competitors in chronic care medicines while maintaining slightly higher prices in lifestyle and wellness categories due to bundled offers and loyalty programs. These patterns remained consistent between 2020 and 2026, making Netmeds a preferred platform for long-term medication purchases.
| Segment | Avg. Price Difference |
|---|---|
| Chronic Medicines | –10% |
| Acute Medicines | –4% |
| Lifestyle Drugs | +6% |
| Wellness Products | +8% |
Understanding these differences helps manufacturers align channel-specific pricing strategies and negotiate platform partnerships more effectively.
Large-scale pricing analytics require standardized, normalized, and validated datasets. With Web Scraping Medicine pricing data, businesses can consolidate millions of listings across PharmEasy, 1mg, and Netmeds into a single analytical framework.
From 2020 to 2026, structured scraping enabled tracking of over 300,000 unique medicine SKUs, accounting for dosage variations, pack sizes, and brand aliases. This level of normalization ensures accurate price comparisons and reduces analytical errors caused by inconsistent product naming.
| Metric | Volume |
|---|---|
| Total SKUs Tracked | 300,000+ |
| Daily Listings Processed | 1M+ |
| Data Accuracy | 99% |
| Historical Coverage | 6+ Years |
Unified datasets support AI-driven analytics, demand forecasting, and long-term pricing simulations.
Strategic decision-making relies on understanding how discounts impact consumer behavior. Using Competitive pricing analysis in pharma, organizations can measure how discount depth correlates with conversions, retention, and revenue.
Data from 2020 to 2026 indicates that discounts between 20% and 30% yield the highest conversion uplift. Beyond this threshold, margin erosion outweighs incremental demand gains, signaling discount saturation.
| Discount Range | Conversion Lift |
|---|---|
| 10–20% | 1.2× |
| 20–30% | 1.8× |
| 30–40% | 1.6× |
| 40%+ | 1.3× |
These insights help brands and platforms maintain sustainable pricing while remaining competitive.
Effective Price Monitoring ensures real-time visibility into sudden price hikes, stock shortages, regulatory changes, and promotional spikes. Between 2022 and 2026, organizations using automated monitoring reduced response times by over 60%, enabling faster repricing and inventory adjustments.
Real-time alerts also help detect anomalies such as unauthorized discounting, price undercutting, or supply disruptions across regions.
| KPI | Improvement |
|---|---|
| Response Time | –60% |
| Pricing Accuracy | +35% |
| Revenue Protection | +22% |
| Compliance Tracking | +30% |
Such monitoring is critical in a regulated and highly competitive pharma environment.
Actowiz Solutions specializes in enterprise-grade Pharmaceutical Data Scraping tailored for India’s online healthcare ecosystem. Our advanced data pipelines support large-scale Tracking Medicine Prices - PharmEasy, 1mg & Netmeds, enabling businesses to capture historical trends, real-time price changes, and platform-level discount strategies with high accuracy.
We deliver customized dashboards, automated alerts, and analytics-ready datasets that empower pharmaceutical manufacturers, healthcare startups, insurers, and research institutions to make data-backed decisions. Actowiz ensures compliance, scalability, and reliability across millions of daily data points.
In today’s dynamic digital healthcare landscape, Tracking Medicine Prices - PharmEasy, 1mg & Netmeds is essential for maintaining pricing transparency, competitiveness, and consumer trust. Actowiz Solutions leverages advanced Web Scraping, robust Mobile App Scraping, and scalable Real-time dataset architectures to deliver accurate, actionable, and future-ready pricing intelligence.
Partner with Actowiz Solutions today to transform raw medicine pricing data into strategic healthcare insights and stay ahead in India’s fast-evolving online pharma market!
You can also reach us for all your mobile app scraping, data collection, web scraping , and instant data scraper service requirements!
Our web scraping expertise is relied on by 4,000+ global enterprises including Zomato, Tata Consumer, Subway, and Expedia — helping them turn web data into growth.
Watch how businesses like yours are using Actowiz data to drive growth.
From Zomato to Expedia — see why global leaders trust us with their data.
Backed by automation, data volume, and enterprise-grade scale — we help businesses from startups to Fortune 500s extract competitive insights across the USA, UK, UAE, and beyond.
We partner with agencies, system integrators, and technology platforms to deliver end-to-end solutions across the retail and digital shelf ecosystem.
Extract real-time travel mode data via APIs to power smarter AI travel apps with live route updates, transit insights, and seamless trip planning.
How a $50M+ consumer electronics brand used Actowiz MAP monitoring to detect 800+ violations in 30 days, achieving 92% resolution rate and improving retailer satisfaction by 40%.

Track UK Grocery Products Daily Using Automated Data Scraping across Morrisons, Asda, Tesco, Sainsbury’s, Iceland, Co-op, Waitrose, and Ocado for insights.
Whether you're a startup or a Fortune 500 — we have the right plan for your data needs.